Modalis Therapeutics Corporation (TYO:4883)
Japan
· Delayed Price · Currency is JPY 84.00
-2.00 (-2.33%)
Jun 26, 2025, 3:24 PM JST
Modalis Therapeutics Market Cap
Modalis Therapeutics has a market cap or net worth of 6.46 billion as of June 26, 2025. Its market cap has increased by 154.52% in one year.
Market Cap
6.46B
Enterprise Value
2.90B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
84.00
Market Cap Chart
Since August 3, 2020, Modalis Therapeutics's market cap has decreased from 60.66B to 6.46B, a decrease of -89.35%. That is a compound annual growth rate of -36.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 25, 2025 | 6.62B | -6.55% |
| Dec 30, 2024 | 7.08B | 80.79% |
| Dec 29, 2023 | 3.92B | -59.92% |
| Dec 30, 2022 | 9.77B | -44.97% |
| Dec 30, 2021 | 17.75B | -71.83% |
| Dec 30, 2020 | 63.03B | 3.92% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 12.40T |
| Takeda Pharmaceutical Company | 6,690.91B |
| Daiichi Sankyo Company | 6,281.29B |
| HOYA Corporation | 5,895.44B |
| Terumo | 3,945.50B |
| Otsuka Holdings | 3,735.96B |
| Astellas Pharma | 2,489.14B |
| Shionogi & | 2,165.85B |